fbpx
Prostate Cancer: Early Detection Guidelines

 

According to the Prostate Cancer Foundation, prostate cancer is typically slow growing, often causing no symptoms until it reaches a more advanced stage. Once the disease begins to grow more rapidly or spreads outside the prostate, it can become a larger health problem. This aggressive type of prostate cancer can occur at any age, though […]

 

Learn More

 

 

Treatment Options for Prostate Cancer

 

According to the American Cancer Society, more than 7,000 New Jersey men will be diagnosed with prostate cancer this year. The appropriate treatment option can vary greatly depending on a number of factors including the stage, grade of the tumor, age, health and lifestyle of the patient. New Jersey CyberKnife treats prostate cancer with stereotactic […]

 

Learn More

 

 

New Jersey CyberKnife Shares Advancements in Research, Prostate Cancer Treatment

 

As New Jersey CyberKnife collaborates with the University of Pittsburgh to offer an ongoing clinical trial examining stereotactic body radiation therapy (SBRT) for prostate cancer treatment, the center’s medical director, Dr. David D’Ambrosio, is spearheading an analysis of national data on CyberKnife SBRT treatment outcomes and plans to publish his findings. “The research our physician […]

 

Learn More

 

 

Prostate Cancer Awareness Month

 

This week marks the beginning of Prostate Cancer Awareness Month, which is dedicated to raising awareness, advocating for research and educating men on how to maintain their prostate health. Here’s how you and your loved ones can participate in Prostate Cancer Awareness Month: Be informed. Prostate cancer is the second most common cancer in American […]

 

Learn More

 

 

Celebrate Men’s Health Month in June

 

June is Men’s Health Month! This time is dedicated to raising awareness of preventable health problems men may encounter through health education, fundraising and advocacy efforts promoting early detection and treatment of disease. Here’s how you can get involved: Wear blue. The Men’s Health Network created the initiative to support men’s health efforts. Learn more […]

 

Learn More

 

 

Prostate Cancer Series: Understanding the Treatment Process

 

New Jersey CyberKnife is committed to helping patients understand their diagnosis and the treatment process. The video below provides an overview of how CyberKnife® treats prostate cancer and the benefits of using this advanced technology. This post is part of a series dedicated to addressing one of the most important health issues facing men today. […]

 

Learn More

 

 

ASTRO Endorses Stereotactic Body Radiation Therapy As First-Line Prostate Cancer Treatment Option

 

The American Society for Radiation Oncology has announced the classification of stereotactic body radiation therapy as a first-line treatment option for prostate cancer. As a first-line treatment, SBRT can be considered a primary form of treatment for prostate cancer. The results of long-term clinical trials supporting the safety and efficacy of stereotactic body radiation in […]

 

Learn More

 

 

Spotlight On: Prostate Cancer Foundation

 

The Prostate Cancer Foundation (PCF) is a dynamic organization committed to funding cutting-edge prostate cancer research. Since 1993, the PCF has funded more than 1,600 programs at nearly 200 research facilities around the world. In 2012, the organization raised a record $47 million and expanded their research programs to China. Each year, the PCF partners […]

 

Learn More

 

 

From the Doc: Benefits of CyberKnife for Prostate Cancer Patients

 

Find out how stereotactic body radiation therapy (SBRT) with CyberKnife® can benefit prostate cancer patients. Below are some advantages from our medical director Dr. David D’Ambrosio. What sets CyberKnife apart from other treatment options?CyberKnife offers patients a noninvasive treatment option that doesn’t impede on their lifestyle. CyberKnife can treat prostate cancer patients in five or […]

 

Learn More

 

 

Research Notes: High-dose Stereotactic Body Radiotherapy Effective, Quick for Localized Prostate Cancer

 

In a study presented at the annual meeting of the American Society of Radiation Oncology, researchers found that men with organ-confined prostate cancer can be treated successfully with stereotactic body radiation therapy. The five-year, multi-center study evaluated low-risk, intermediate-risk and high-risk patients for up to four years following treatment. At the five-year mark, the relapse-free […]

 

Learn More